October 26, 2006

Merck / Johnson & Johnson/ Lilly-Zyprexa: $690 Million settlement / a Flowering of Diabetes Drugs Fri, 10

Read More
Merck / Johnson & Johnson/ Lilly-Zyprexa: $690 Million settlement / a Flowering of Diabetes Drugs

October 26, 2006

Mosholder Suppressed Report Posted/ Bush Moves to Block Medical Suits – NYT Mon, 26 Jul 2004 The

Read More
Mosholder Suppressed Report Posted/ Bush Moves to Block Medical Suits – NYT

October 26, 2006

FDA Underhanded Tactics Against Medical Officer Who Blew the Whistle Mon, 29 Nov 2004 The Food and

Read More
FDA Underhanded Tactics Against Medical Officer Who Blew the Whistle

October 26, 2006

How Did the Vioxx Debacle Happen? USA Today / Lancet Tue, 12 Oct 2004 Dr. Eric Topol

Read More
How Did the Vioxx Debacle Happen? USA Today / Lancet

October 26, 2006

Trial Lawyers Are Taking Aim at the Drug Industry_NYT Sun, 18 May 2003 It appears that trial

Read More
Trial Lawyers Are Taking Aim at the Drug Industry_NYT

January 14, 2006

Such payments are, in fact,  kick backs for these groups’ promotional services encouraging doctors to prescribe drugs

Read More
S. Finance Committee Investigates Drug Makers Over Medical Education Grants_NYT

September 12, 2005

Abbott Seeks FDA approval for cancer drug despite failed trials – WSJ Mon, 12 Sep 2005 Abbott

Read More
Abbott Seeks FDA approval for cancer drug despite failed trials – WSJ

July 18, 2005

THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org CHEAPER THAN CHIMPANZEES Statement Presented By VERA HASSNER SHARAV

Read More
2005: “Cheaper than Chimpanzees” by Vera Sharav

June 10, 2005

http://www.nytimes.com/2005/06/10/business/10drug.html?ei=5094&en=5475b3c17e50e692&hp =&ex=1118462400&partner=homepage&pagewanted=print THE NEW YORK TIMES June 10, 2005, front page Lucrative Drug, Danger Signals and the

Read More
Lucrative Drug, Danger Signals and the F.D.A. – NY Times

August 18, 2003

Comments submitted by The Alliance for Human Research Protection The National Academy of Sciences Committee of the

Read More
Best Pharmaceuticals for Children Act of 2002

January 15, 2003

References for THE IMPACT OF THE FDA MODERNIZATION ACT ON THE RECRUITMENT OF CHILDREN FOR RESEARCH Vera

Read More
References: Impact of FDA inclusion of children as test subjects

May 14, 2002

Dissenting Opinion (NHRPAC Children Workgroup) re: Proposed Reinterpretation of Fed. Regs Protecting Children (45 CFR 46, sections

Read More
Dissenting Opinion – Proposed Children’s Workgroup Reinterpretation of Fed Regs 45 CFR 46 sects. 404 & 406

May 7, 2002

Presented by Vera Hassner Sharav 14th Tri-Service Clinical Investigation Symposium Sponsored by The U.S. Army Medical Department

Read More
Conflicts of Interest in Clinical Trials

May 5, 2002

CONFLICTS OF INTEREST Presented by Vera Hassner Sharav 14th TRI-SERVICE CLINICAL INVESTIGATION SYMPOSIUM Sponsored By THE U.S.

Read More
Sharav Presentation before US Army Medical Dept., May 6, 2002